The resolution raises awareness and documents substantial health and economic harms from PCOS—potentially increasing diagnosis, mental‑health attention, and justification for funding—while stopping short of providing funding or policy changes, which may create unmet expectations and short‑term cost or stigma risks.
Women and girls with PCOS (and clinicians who treat them) would gain greater visibility of a common, costly condition, making diagnosis and care pathways more likely to be recognized and prioritized.
Women with PCOS would have increased recognition of mental-health risks (depression, anxiety, suicide risk), which could prompt better screening and referrals for behavioral health services.
Taxpayers and policy makers would receive documentation of the large economic burden (>$15 billion) from PCOS, strengthening the case for targeted research, funding, or program investments to reduce long-term healthcare and productivity costs.
Women and families could have raised expectations that services, coverage, or new programs will follow the findings even though the resolution does not provide funding or policy changes.
Highlighting high prevalence and costs may increase demand for diagnostics and specialist care, producing higher short-term out‑of‑pocket and insurer costs if coverage or capacity does not expand.
Publicizing genetic correlations and long-term risks without clear guidance or supports could cause anxiety, stigma, or discrimination concerns for some patients.
Based on analysis of 2 sections of legislative text.
Officially records findings on PCOS prevalence, health and economic burden, high underdiagnosis, associated risks, and gaps in definition and cure.
Introduced September 30, 2025 by Elizabeth Warren · Last progress October 6, 2025
Declares formal findings about polycystic ovary syndrome (PCOS), describing how common it is, its medical features and related health risks, the large economic burden, and a high rate of undiagnosed cases. Notes that PCOS often begins at puberty, can persist across the lifespan, lacks a single universal definition and a cure, and is linked to metabolic and mental health conditions.